Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy
Open Access
- 1 June 1998
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 41 (3), 511-517
- https://doi.org/10.1016/s0360-3016(98)00104-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.Journal of Clinical Oncology, 1996
- Prostate Specific Antigen Following Radiotherapy for Local Prostate CancerJournal of Urology, 1995
- Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment OutcomeJournal of Urology, 1994
- Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapyCancer, 1993
- Localized prostate cancer: use of serial prostate-specific antigen measurements during radiation therapy.Radiology, 1992
- Prostate Specific Antigen Levels After Radical Prostatectomy in Patients with Organ Confined and Locally Extensive Prostate CancerJournal of Urology, 1992
- A prospective study of prostate specific antigen levels in patients receiving radiotherapy for localized carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989
- Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical ProstatectomyJournal of Urology, 1988